Botulinum Toxin Injection in the Treatment of Open Abdomen

NCT04283916 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2024-02-01

No results posted yet for this study

Summary

Botulinum toxin has been widely approved and utilized in the treatment of complex abdominal wall hernias. Botulinum toxin has been only randomly studied in the treatment of open abdomen.

Conditions

  • Open Abdomen
  • Botulinum Toxin Injection

Interventions

DRUG

Botulinum Toxins

Botulinum toxin injection to abdominal wall

Sponsors & Collaborators

  • University of Oulu

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-21
Primary Completion
2024-06-30
Completion
2024-08-31
FDA Drug
Yes

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04283916 on ClinicalTrials.gov